Cerebro NeuroTech was founded with the mission to revolutionize concussion detection and diagnosis through advanced AI technology. The company's core product, Trinity, is a physiological and cognitive predictive AI digital human designed to rapidly detect concussions at the onset of injury. Focused primarily on the sports industry, Cerebro NeuroTech aims to provide accurate, real-time assessments to improve player safety and health outcomes.
Notable affiliates include experts in AI and neurology, contributing to the development of their cutting-edge software. The company has garnered attention from prominent investors and media outlets like Sports Business Journal and Miami Herald for its innovative approach. Cerebro NeuroTech's key achievements include significant advancements in concussion detection accuracy, positioning it as a leader in sports health technology and making a substantial impact on athlete safety.
